HDAC-IN-71
Based on 1 publication(s) in Google Scholar
HDAC-IN-71 (Compound 17q) is a potent HDAC inhibitor with IC50 values of 12.6, 14.1, 20, 3, and 72 nM for HDAC1, HDAC2, HDAC3, HDAC6, and HDAC10, respectively. HDAC-IN-71 induces apoptosis and can be used in cancer research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2995354-52-2
- 分子式: C19H24N2O5
- 分子量:360.40
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
MedChemExpress(MCE)の使用を引用している文献 HDAC-IN-71
More
生物活性
|
HDAC1 12.6 nM (IC50) |
HDAC2 14.1 nM (IC50) |
HDAC3 20 nM (IC50) |
HDAC6 3 nM (IC50) |
HDAC10 72 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
1.39 μM
Compound: 17q
|
Antiproliferative activity against human A549 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human A549 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| DU-145 | IC50 |
0.16 μM
Compound: 17q
|
Antiproliferative activity against human DU-145 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human DU-145 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| HCT-116 | IC50 |
0.47 μM
Compound: 17q
|
Antiproliferative activity against human HCT-116 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| HT-29 | IC50 |
1.05 μM
Compound: 17q
|
Antiproliferative activity against human HT-29 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human HT-29 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| LNCaP | IC50 |
0.63 μM
Compound: 17q
|
Antiproliferative activity against human LNCaP cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human LNCaP cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| MCF7 | IC50 |
0.35 μM
Compound: 17q
|
Antiproliferative activity against human MCF7 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human MCF7 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| MDA-MB-231 | IC50 |
0.31 μM
Compound: 17q
|
Antiproliferative activity against human MDA-MB-231 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| NCI-H1650 | IC50 |
3.56 μM
Compound: 17q
|
Antiproliferative activity against human NCI-H1650 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human NCI-H1650 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| NCI-H446 | IC50 |
0.65 μM
Compound: 17q
|
Antiproliferative activity against human NCI-H446 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human NCI-H446 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| PC-3 | IC50 |
0.72 μM
Compound: 17q
|
Antiproliferative activity against human PC-3 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human PC-3 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
HDAC-IN-71 (0-1.6 μM; 24 h) inhibits colony formation in a dose-dependent manner and completely inhibits colony formation of DU145 cells at a concentration of 3.2 μM[1].
HDAC-IN-71 (0-1.6 μM; 72 h) arrests cells in G2/M phase and induces apoptosis in DU145 cell line in a concentration-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:DU145 cells
-
Concentration:0, 0.2, 0.4, 0.8, 1.6 μM
-
Incubation Time:12 h
-
Result:Inhibited cancer cell migration.
-
Cell Line:DU145 cells
-
Concentration:0, 0.2, 0.4, 0.8, 1.6 μM
-
Incubation Time:72 h
-
Result:Arrested cells in G2/M phase in a dose-dependent manner.
-
Cell Line:DU145 cells
-
Concentration:0.8, 1.6, 3.2 μM
-
Incubation Time:24 h
-
Result:Induced histone acetylation and inhibited HDAC6 expression.
Pharmacokinetic analysis[1]
| Parameters | I.V. (2 mg/kg) | P.O. (10 mg/kg) |
| AUC0-∞ (h ng/mL) | 1633.35 | 3799.46 |
| T1/2 (h) | 3.12 | 2.87 |
| CL (L/h/kg) | 1.57 | |
| V (L/kg) | 4.63 | |
| Cmax(ng/mL) | 851.5 | 774.0 |
| F | 46.52% |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Balb/c nude mice[1]
-
Dosage:100, 200 mg/kg
-
Administration:Oral administration; daily; 40 days
-
Result:Significantly inhibited prostate cancer (PCa) tumor growth.
化学情報
-
CAS 番号 2995354-52-2
-
分子量 360.40
-
分子式 C19H24N2O5
-
SMILES
COC1=C(C=CC=C1)/C=C2CC(N(C\2=O)CCCCCCC(NO)=O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)